Back to Journals » ClinicoEconomics and Outcomes Research » Volume 8
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
23,070 | Dovepress* | 12,756+ | 2,214 | 14,970 | |
PubMed Central* | 10,314 | 893 | 11,207 | ||
Totals | 23,070 | 3,107 | 26,177 | ||
*Since 20 May 2016 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
8 | 0 | 0 | 0 | 3 | 5 |
View citations on PubMed Central and Google Scholar